Publications by authors named "Mark Temper"

Claim this Profile
N
Neoadjuvant SBRT and intraoperative electron radiotherapy in pancreatic cancer resection.
Gianella Cornejo, Alon Pikarsky, Ayala Hubert, Marc Wygoda, Antoni Skripai, Mark Temper

J Cancer Res Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of tissue-free minimal residual disease testing in colorectal cancer patients from Asia and Middle East.
Suyog Jain, Shaheenah Dawood, Viraj Lavingia, Dan Aderka, Esther Tahover, Mark Temper

Front Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiplexed, single-molecule, epigenetic analysis of plasma-isolated nucleosomes for cancer diagnostics.
Vadim Fedyuk, Nir Erez, Noa Furth, Olga Beresh, Ekaterina Andreishcheva, Mark Temper

Nat Biotechnol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid biopsy reveals collateral tissue damage in cancer.
Asael Lubotzky, Hai Zemmour, Daniel Neiman, Marc Gotkine, Netanel Loyfer, Mark Temper

JCI Insight· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholangiocarcinoma: An Emerging Target for Molecular Therapy.
Ilya Tsimafeyeu, Mark Temper

Gastrointest Tumors· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin.
Ronen Sadeh, Israa Sharkia, Gavriel Fialkoff, Ayelet Rahat, Jenia Gutin, Mark Temper

Nat Biotechnol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin.
Ronen Sadeh, Israa Sharkia, Gavriel Fialkoff, Ayelet Rahat, Jenia Gutin, Mark Temper

Nat Biotechnol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin.
Ronen Sadeh, Israa Sharkia, Gavriel Fialkoff, Ayelet Rahat, Jenia Gutin, Mark Temper

Nat Biotechnol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Splicing Factor Transcript Abundance in Saliva as a Diagnostic Tool for Breast Cancer.
Mercedes Bentata, Guy Morgenstern, Yuval Nevo, Gillian Kay, Avital Granit Mizrahi, Mark Temper

Genes (Basel)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience.
Ofer Purim, Alexander Beny, Moshe Inbar, Katerina Shulman, Baruch Brenner, Mark Temper

Target Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patients.
Aviad Zick, Tamar Peretz, Michal Lotem, Ayala Hubert, Daniela Katz, Mark Temper

Medicine (Baltimore)· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Profiling-Selected Therapy for Treatment of Advanced Pancreaticobiliary Cancer: A Retrospective Multicenter Study.
Ron Epelbaum, Einat Shacham-Shmueli, Baruch Klein, Abed Agbarya, Baruch Brenner, Mark Temper

Biomed Res Int· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An observational cohort study of bevacizumab and chemotherapy in metastatic colorectal cancer patients: safety and efficacy with analysis by age group.
Esther Tahover, Ayala Hubert, Mark Temper, Azzam Salah, Tamar Peretz

Target Oncol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Inguinal Involvement of Peritoneal Surface Malignancies by Cytoreduction and HIPEC with Inguinal Perfusion.
Yair Shachar, Mohamed Adileh, Assaf Keidar, Luminita Eid, Ayalah Hubert, Mark Temper

J Cancer· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypertension as a predictive biomarker in bevacizumab treatment for colorectal cancer patients.
Esther Tahover, Beatrice Uziely, Azzam Salah, Mark Temper, Tamar Peretz

Med Oncol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of founder BRCA1 and BRCA2 mutations in cutaneous malignant melanoma patients of Ashkenazi origin.
Luna Kadouri, Mark Temper, Tal Grenader, Dvorah Abeliovich, Tamar Hamburger

Fam Cancer· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of pathological humeral shaft fractures with unreamed humeral nail.
Kivanc Atesok, Meir Liebergall, Erwin Sucher, Mark Temper, Rami Mosheiff

Ann Surg Oncol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis